The research institute of Migal Galilee uses applications of BIOVIA for development of vaccine against COVID-19

2020: Use of BIOVIA for development of vaccine against COVID-19

The research institute of Migal Galilee uses applications of BIOVIA from Dassault Systèmes for development of vaccine against COVID-19. It became known on July 7, 2020.

In the conditions of COVID-19 pandemic representatives of the medicobiological industry are engaged in search of methods of control of spread of a virus and counteraction to a disease worldwide.

Specialists of Migal Galilee within four years used applications of BIOVIA along with other computing tools for carrying out cross-disciplinary researches within projects on development of the vaccines against a bird's coronavirus (avian coronavirus, IBV). When it was announced COVID-19 pandemic, experts of the research center specializing in researches in the field of applied botany, agriculture, the environment, information technologies, a power supply and biotechnologies began to use the accumulated knowledge and abilities of work with applications for studying of mutations of COVID-19. Experts set a goal to create the vaccine against new type of a coronavirus for people, in vivo, suitable for carrying out preclinical tests, in 90 days.

During COVID-19 pandemic platform 3DExperience and digital applications of Dassault Systèmes can help the health care industry with the most different aspects – from carrying out scientific research and clinical trials before production and rendering medical services.

Application of applications of BIOVIA for development of vaccine from COVID-19 allows Migal Galilee to regulate the course of laboratory and experimental works, using the digital approach allowing to accelerate obtaining results of researches. Scientists can quickly process and analyze the data collected for the last four years now and also model structure of virus protein and change of the predicted virusneytralizuyushchy anti-gene determinant. All this gives the chance to interpret results of tests, relying on experience of the previous researches and to select optimal strategy for further work.

The BIOVIA Pipeline Pilot application accelerates process of researches due to support of rapid development and deployment of uniform digital mediums for data analysis. All this will help to accelerate development of the scientific ideas suitable for implementation. The BIOVIA Discovery Studio application provides a full range of methods of modeling and simulation for studying of features of chemistry of proteins and also creation of medicines on the basis of small and large molecules – from identification of molecules targets before optimization of leading connections.